Finance

Beta
Lists
PPGN:SWX
Polypeptide Group AG
CHF 37.70
+1.34%
(+0.50) 1D
Jun 4, 5:30:15 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for PPGN...
Open
CHF 37.35
High
CHF 37.80
Low
CHF 36.25
Mkt. cap
1.25B
Avg. vol.
66.13K
Volume
66.98K
52-wk high
CHF 41.70
52-wk low
CHF 19.62
EPS
-CHF 0.58
Shares outstanding
33.13M
No. of employees
1K
Open
CHF 37.35
High
CHF 37.80
Low
CHF 36.25
Mkt. cap
1.25B
Avg. vol.
66.13K
Volume
66.98K
52-wk high
CHF 41.70
52-wk low
CHF 19.62
EPS
-CHF 0.58
Shares outstanding
33.13M
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to PPGN in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PPGN in the last 3 months.
Highest
Current CHF 37.70
CHF 44.00 (+16.71%)
Average
CHF 39.67 (+5.23%)
Lowest
CHF 35.00 (-7.16%)
News stories
From sources across the web
About Polypeptide Group AG
CEO-
Employees1.44K
Founded1952
HeadquartersBaar, Zug, Switzerland
SectorHealth care
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
83.55M
83.55M
111.12M
111.12M
Cost of goods sold
76.65M
76.65M
85.37M
85.37M
Cost of revenue
76.65M
76.65M
85.37M
85.37M
Research and development expenses
454.50K
454.50K
686.50K
686.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.55M
13.55M
14.27M
14.27M
Operating expense
13.76M
13.76M
14.65M
14.65M
Total operating expenses
90.41M
90.41M
100.02M
100.02M
Operating income
-6.86M
-6.86M
11.10M
11.10M
Other non operating income
-
-
-508.50K
-508.50K
EBT including unusual items
-15.53M
-15.53M
5.50M
5.50M
EBT excluding unusual items
-15.53M
-15.53M
5.43M
5.43M
Income tax expense
-2.26M
-2.26M
2.81M
2.81M
Effective tax rate
14.54%
14.54%
51.17%
51.17%
Other operating expenses
-251.50K
-251.50K
-301.00K
-301.00K
Net income
-13.27M
-13.27M
2.68M
2.68M
Net profit margin
-15.88%
-15.88%
2.42%
2.42%
Earnings per share
-
-
-
-
Interest and investment income
246.00K
246.00K
976.50K
976.50K
Interest expense
-8.91M
-8.91M
-
-
Net interest expenses
-8.67M
-8.67M
976.50K
976.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
2.22M
2.22M
16.83M
16.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more